Cancer Weekly articles from February 1993

Cancer Weekly archives from February 1993

Scientists to start tests on anticancer vaccine. (Epstein-Barr virus vaccine) (London)
February 1, 1993... London Clinical tests on the first antiviral vaccine for cancer will begin on patients in Britain by the end of 1993, the Cancer Research Campaign (CRC) said. The vaccine, developed by United Kingdom scientists and funded by the...

Moving forward with a "second generation" lymphoma vaccine. (B-cell lymphoma) (U.S. National Cancer Institute)
February 1, 1993... U.S. NCI Researchers at the U.S. National Cancer Institute (NCI) are developing a "second generation" cancer vaccine for B-cell lymphoma, following the encouraging results of a small-scale vaccine trial at Stanford University Medical...

Researchers make gene discovery. (gene involved in development of acute leukemia) (Jefferson Cancer Institute)
February 1, 1993... Jefferson Cancer Institute Dr. Eli Canaani, whose cancer research was supported for ten years by the Israel Cancer Research Fund (ICRF), is co-author of a new study on leukemia which was recently published in the journal Cell. ...

Opportunities seen for gene therapy. (U.S. National Cancer Institute)
February 1, 1993... U.S. NCI Scientists from Italy and the U.S. met recently at the National Institute for Cancer Research in Genoa to talk about gene therapy for acute lymphocytic leukemia, lung and brain cancers, and even AIDS. The meeting was held under...

Radioactive treatment at six cancer centers halted. (Oncology Services Corp.'s afterloader treatment suspended due to safety concerns) (U.S. Nuclear Regulatory Commission)
February 1, 1993... U.S. NRC Few of the patients treated at six Pennsylvania cancer centers were affected by the U.S. Nuclear Regulatory Commission's (NRC) decision to halt a specific treatment the facilities offered, an official said. The NRC ordered...

Study indicates widespread exposure to tobacco smoke. (U.S. Centers for Disease Control and Prevention)
February 1, 1993... U.S. CDC Exposure is apparently widespread to tobacco smoke, which the U.S. Environmental Protection Agency recently classified as a potent health risk, the preliminary results of a government study showed (see Periodical Report, this...

Motorola defends cellular phones against their link to brain cancer. (Florida)
February 1, 1993... Florida Motorola Inc., a cellular-phone maker, said that thousands of tests have proven the devices are safe, and that recent suggestions that portable phones might be linked to brain cancer are unfounded. A St. Petersburg, Florida,...

Smoking interferes with effects of cancer treatment. (Canada)
February 1, 1993... Canada Cigarette smoking appears to lower the chances of surviving treatment for cancer of the throat and mouth, doctors say. A study found that people who continue to smoke during radiation therapy for this kind of cancer fare...

Bristol-Myers Squibb to joust over taxol prices. (Washington, D.C.)
February 1, 1993... Washington, D.C. Representative Ron Wyden is taking on one of the world's largest pharmaceutical companies over the government's power to regulate prices for lifesaving drugs such as Taxol. Taxol, extracted from the Pacific yew...

ESCAgenetics signs collaboration with Genencor to scale-up taxol production. (Genencor International Inc.) (California)
February 1, 1993... California ESCAgenetics Corporation, San Carlos, California, announced it has entered into an agreement to scale-up Taxol production through its proprietary plant cell tissue culture process in a collaboration with Genencor International...

Insurer using cancer tests described by critics as unproven. (Transamerica Occidental Life Insurance Co.; cancer screening tests) (California)
February 1, 1993... California The California state Insurance Department is investigating a company's use of an unapproved cancer screening test on thousands of applicants. The department said it opened a probe into Transamerica Occidental Life...

Myths about cancer lead to workplace discrimination. (Cerenex Pharmaceuticals survey)
February 1, 1993... Cerenex Pharmaceuticals Results of a national poll indicate that when employees are diagnosed with cancer, their supervisors and coworkers may react according to preconceived ideas about the disease as well as prejudice against the...

Researchers use decoy peptides to block cell growth. (Thomas Jefferson University)
February 1, 1993... Thomas Jefferson University Using the sophisticated techniques of computer-aided molecular design to target a recently identified "crucial step" in normal and tumor cell growth, researchers at Thomas Jefferson University, Philadelphia,...

Head and neck cancer reviewed. (U.S. National Cancer Institute)
February 1, 1993... U.S. NCI In a review appearing in the January 20, 1993, issue of the Journal of the National Cancer Institute (NCI), Dimery and Hong discuss the evolution of treatment for head and neck cancer over the past 10 years toward a combined...

Nm23-H1 and nm23-H2 expression examined. (U.S. National Cancer Institute)
February 1, 1993... U.S. NCI Past studies have suggested that the nm23 gene might suppress metastases in malignant rodent tumors as well as in human breast and colon cancers. The new study, appearing in the January 20, 1993, issue of the Journal of the...

AMDL files broader patent application for RSP cancer-detection biotechnology. (Ring-Shaped Particle) (California)
February 1, 1993... California AMDL Inc., Pasadena, California, has filed a revised, broader patent application covering its proprietary Ring-Shaped Particle (RSP) cancer-detection biotechnology. The application represents a continuation and update of...

Agouron Pharmaceuticals allowed to test AG-331. (thymidylate synthase inhibitor) (U.S. Food and Drug Administration)
February 1, 1993... U.S. FDA Agouron Pharmaceuticals Inc. announced that it has been authorized by the U.S. Food and Drug Administration (FDA) to begin clinical testing of its antitumor drug designated AG-331. As a result of the FDA action, a Phase I...

IND for bispecific antibody for the treatment of breast and ovarian cancers announced. (Investigational New Drug application) (Medarex Inc.)
February 1, 1993... Medarex, Inc. Medarex, Inc., Princeton, New Jersey, announced that a research team from Dartmouth Medical School has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a...

Breast Cancer Education Summits. (RFA CA-93-17)(research grant announcement) (Research Report)
February 1, 1993... AUTHORS: (RFA CA-93-17) National Cancer Institute, Bethesda, Maryland. "Application Receipt Date: May 7, 1993. Purpose: The purpose of this RFA is to provide support for the planning, implementation and evaluation of Breast Cancer...

Breast Cancer Education Mini-Summits. (RFA CA-93-18)(research grant announcement) (Research Report)
February 1, 1993... Breast Cancer Education Summits AUTHORS: (RFA CA-93-18) National Cancer Institute, Bethesda, Maryland. "Application Receipt Date: May 7, 1993. Purpose: The purpose of this RFA is to provide support for the planning, implementation...

Potential for combination therapy with the new antiserotonergic agents. (Research Report)
February 1, 1993... Potential for Combination Therapy with the New AUTHORS: S.M. Grunberg. University of Southern California, Los Angeles, California. According to the author's abstract of a presentation to the Perugia International Cancer Conference...

Reliability and validity of a quality of life questionnaire in cancer patients. (Research Report)
February 1, 1993... Reliability and Validity of a Quality of Life AUTHORS: E. Ballatori, F. Roila, C. Basurto, S. Bracarda, M. Picciafuoco, M. Soldani, L. Crino, M. Tonato, G. Milella and A. Del Favero. University of Perugia, Perugia, Italy. ...

The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients. (Research Report)
February 1, 1993... The New Fluorinated Quinolones for Antimicrobial AUTHORS: Albano Del Favero and Francesco Menichetti. University of Perugia, Perugia, Italy. According to the authors' abstract of a presentation to the Perugia International Cancer...

Delayed emesis following high-dose cisplatin: a double-blind randomized comparative trial of ondansetron (GR 38032F) versus placebo. (Research Report)
February 1, 1993... AUTHORS: D.R. Gandara, W.H. Harvey, G.G. Monaghan, E.A. Perez and P.J. Hesketh. Boston University School of Medicine, Boston, Massachusetts, and the M.D. Anderson Cancer Center, Houston, Texas. According to the authors' abstract of a...

Quality of life in breast cancer patients: the contribution of data to the care of patients. (Research Report)
February 1, 1993... AUTHORS: B.E. Meyerowitz. University of Southern California, Los Angeles, California. According to the author's abstract of a presentation to the Perugia International Cancer Conference III, held in Perugia, Italy, "A primary test of...

Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). (Research Report)
February 1, 1993... AUTHORS: Patricia J. Hollen, Richard J. Gralla, Mark G. Kris and Lisa M. Potanovich. University of Rochester, Rochester, New York, and Memorial Sloan Kettering Cancer Center, New York, New York. According to the authors' abstract of a...

Characteristics related to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. (Periodical Report)
February 1, 1993... SOURCE: Journal of the National Cancer Institute, January 20, 1993;85(2):142-147 The lowered incidence of ovarian cancer in black women was not explained by different lifestyles in the first published study of ovarian cancer risk in...

Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. (Periodical Report)
February 1, 1993... SOURCE: Annals of Internal Medicine, January 15, 1993;118(2):106-111. The inherited 3;8 translocation and loss of the translocated distal chromosome 3p in familial renal cell tumors may help localize the gene or genes involved in the...

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. (Periodical Report)
February 1, 1993... SOURCE: Cancer, January 1, 1993;71(1):19-43. Despite high recurrence rate after resection of hepatocellular carcinoma (HCC), the use of multiple therapies can result in increased survival rates, according to a report from Japan. ...

Caloric restriction and intervention in pancreatic carcinogenesis in the rat. (Periodical Report)
February 1, 1993... SOURCE: Cancer Research, January 1, 1993;53:46-52. The postinitiation phase of pancreatic cancer can be modulated by caloric restriction, according to a report from New Hampshire's Dartmouth Medical School. Pancreatic cancer is...

Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas. (Periodical Report)
February 1, 1993... SOURCE: Journal of the National Cancer Institute, January 20, 1993;85(2):132-141. The retinoblastoma susceptibility gene (RB1) is structurally and functionally normal in childhood rhabdomyosarcoma, suggesting that the gene does not play...

Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. (Periodical Report)
February 1, 1993... SOURCE: Cancer, January 1, 1993;71(1):62-65. Treatment involving the use of percutaneous transcatheter hepatic arterial chemotherapy and embolization appears to be promising in liver cancer patients who have previously been denied...

Preliminary data: exposure of persons aged greater than 4 years to tobacco smoke - United States, 1988-1991. (Periodical Report)
February 1, 1993... SOURCE: Morbidity and Mortality Weekly Report, Volume 42, No. 02, January 22, 1993. "The recent report of the U.S. Environmental Protection Agency on the respiratory health effects of passive smoking and the known adverse effects of...

Society urges continued adherence to mammography guidelines. (American Cancer Society)
February 8, 1993... American Cancer Society The American Cancer Society, at the end of a two-day workshop reviewing new worldwide data on breast cancer screening in younger women, urged women to follow its current screening mammography guidelines. The...

Breast cancer: increased early detection leads to increased incidence. (American Cancer Society)
February 8, 1993... American Cancer Society The recent increase in the incidence of breast cancer appears to be the result of increased use of mammography and other methods of early detection, according to data presented in the January/February 1993 issue...

Doctor hopes to pinpoint best day for breast cancer surgery. (day in menstrual cycle; Dr. John Spratt) (University of Louisville)
February 8, 1993... University of Louisville Recent research by a University of Louisville (UL), Louisville, Kentucky, surgeon has the potential for being expanded into a national study that could identify the optimum day in a woman's menstrual cycle for...

Mutated p53 gene testing may forecast outcome in node negative breast cancer. (University of Texas Health Science Center)
February 8, 1993... University of Texas Health Science Center Testing for mutated p53 gene protein in breast tumors of women whose cancer is node-negative - that is, it has not spread to underarm lymph nodes - might be a reliable way to identify women with...

Review of literature describes breast cancer in older women. (New England Medical Center)
February 8, 1993... New England Medical Center A literature review by Rebecca Silliman, M.D., Ph.D., et al. in the February 3, 1993, issue of the Journal of the National Cancer Institute summarizes research on early stage breast cancer care for older women....

Breast calcifications: a risk? (Fred Hutchinson Cancer Research Center)
February 8, 1993... Fred Hutchinson Cancer Research Center Calcifications revealed on mammograms are associated with an increased risk of subsequent breast cancer, according to a study by Thomas et al. appearing in the February 3, 1993, issue of the Journal...

Oral contraceptives represent first chemoprevention success, say researchers. (University of Southern California)
February 8, 1993... University of Southern California The use of oral contraceptives has led to a dramatic and largely predictable drop in the number of cases of ovarian and endometrial cancer during the last 30 years, prompting one group of researchers to...

IND filed for trial of bispecific antibody for breast and ovarian cancers. (Investigational New Drug application) (U.S. Food and Drug Administration)
February 8, 1993... U.S. FDA Medarex, Inc., Princeton, New Jersey, announced that a research team from Dartmouth Medical School, Hanover, New Hampshire, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA)...

Bone-marrow transplants now being given on out-patient basis. (Colorado)
February 8, 1993... Colorado In an attempt to cut costs, a team of Denver, Colorado, breast cancer doctors is giving its patients bone-marrow transplants as outpatients rather than secluding them in sterile hospital units for weeks. The doctors hope...

Experts say breast cancer more deadly for younger women. (U.S. National Cancer Institute)
February 8, 1993... U.S. NCI Although breast cancer remains relatively uncommon among younger women, the disease tends to be more fatal when it strikes early in life, experts said. While researchers have begun to understand more about breast cancer in...

Progress in synthetic production of taxol. (Bristol-Myers Squibb Co.)
February 8, 1993... Bristol-Myers Squibb Co. Bristol-Myers Squibb Co. said rapid progress in synthetic production of the anticancer drug Taxol means it can stop harvesting the bark of rare Pacific yew trees in federal forests. The announcement pleased...

FDA approval is not the end: getting the most out of taxol. (Food and Drug Administration) (U.S. National Cancer Institute)
February 8, 1993... U.S. NCI Numerous researchers are working to make Taxol a more effective cancer fighter. At present, the recently approved agent can extend the lives of patients but produces few, if any, cures. And although scientists don't...

Cancer Facts & Figures for 1993 released. (American Cancer Society)
February 8, 1993... American Cancer Society The American Cancer Society has released the 1993 edition of Cancer Facts & Figures, which estimates that in 1993 1,170,000 cases of invasive cancer will be diagnosed in the U.S. Additionally, the Society...

Agency authorizes clinical testing of second Agouron anti-tumor drug. (Agouron Pharmaceuticals Inc.; thymidylate synthase inhibitor, AG-331) (U.S. Food and Drug Administration)
February 8, 1993... U.S. FDA Agouron Pharmaceuticals Inc., San Diego, California, announced that it has been authorized by the U.S. Food and Drug Administration (FDA) to begin clinical testing of its anti-tumor drug designated AG-331. As a result of...

New marker for bladder cancer? (basic fibroblast growth factor) (Harvard Medical School)
February 8, 1993... Harvard Medical School Determining the level of basic fibroblast growth factor (bFGF) in urine may help in diagnosing bladder cancer, say Nguyen et al. in a Brief Communication in the February 3, 1993, issue of the Journal of the...

Peptide G enhances metastasis. (Italy)
February 8, 1993... Italy An in vitro-in vivo murine study by Taraboletti et al. in the February 3, 1993, issue of the Journal of the National Cancer Institute indicates that synthetic peptide G, derived from the 67-kd laminin receptor, enhances the...

Antibodies promise to improve diagnosis of some colon cancers. (Ohio State University)
February 8, 1993... Ohio State University A new diagnostic test has significantly improved the diagnosis of some colon and rectal cancers when used in conjunction with computerized tomography (CT) scans, researchers say. The antibody that makes this...

HTLV-induced human diseases: protective immune responses and potential for vaccine development. (human T-cell lymphotropic virus type-I) (National Cancer Institute research grant announcement) (Research Report)
February 8, 1993... AUTHORS: (RFA CA-93-11) National Cancer Institute, Bethesda, Maryland. "Letter of Intent Receipt Date: March 16, 1993. Application Receipt Date: May 14, 1993. Purpose: The human T-cell lymphotropic virus type I (HTLV-I) is recognized as...

Phase I trials of new anti-cancer agents. (National Cancer Institute research grant announcement) (Research Report)
February 8, 1993... AUTHORS: (RFA CA-93-07) National Cancer Institute, Bethesda, Maryland. Letter of Intent Receipt Date: February 12, 1993. Application Receipt Date: March 23, 1993. The Division of Cancer Treatment of the National Cancer Institute would...

Mammographic surveillance of breast cancer patients: lack of benefit in imaging the post-mastectomy site. (Research Report)
February 8, 1993... AUTHORS: Catherine Roberts, Laurie Fajardo and K. Rebecca Hunt. University of Arizona, Tucson, Arizona. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be held...

A comparison of cognitive feedback and outcome feedback in teaching mammography guidelines to medical students. (Research Report)
February 8, 1993... AUTHORS: A. Chabra and T. Taylor. University of Washington at Seattle. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be held February 17-20, 1993, in Carmel,...

The prevalence, severity and nature of pain in children with leukemia. (Research Report)
February 8, 1993... AUTHORS: Frank N. Johnson and J.S. Miser. University of Washington School of Medicine, Seattle, Washington. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be held...

Use of polymerase chain reaction in detecting human papilloma virus in dual primary tumors of the upper aerodigestive tract. (Research Report)
February 8, 1993... AUTHORS: Robert Kozel, Byron McGregor and Pacito Manalo. University of Nevada School of Medicine, Reno, Nevada. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be...

Synergistic cytotoxicity in vitro of edatrexate and cisplatin in the A549 human non-small cancer cell line. (Research Report)
February 8, 1993... AUTHORS: E.A. Perez and F.M. Sack. University of California at Davis. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be held February 17-20, 1993, in Carmel,...

The effects of caffeine on radiation toxicity for patients treated for cervical and endometrial cancer. (Research Report)
February 8, 1993... AUTHORS: H. Kurtz, K. Stelzer and W.J. Koh. University of Washington, Seattle, Washington. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be held February 17-20,...

Pharmacokinetics of zinc phthalocyanine tetrasulfonate in the tumor-bearing 9L gliosarcoma rat model. (Research Report)
February 8, 1993... AUTHORS: F. Mobin, S.A. Autry and J.E. Boggan. University of California at Davis. According to the abstract of a poster presentation to the meeting of the Western Society for Clinical Investigation, to be held February 17-20, 1993, in...

Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients. (Research Report)
February 8, 1993... AUTHORS: J.D. Cox, T.F. Pajak, S. Asbell, A.H. Russell, J. Pedersen, R. Byhardt, B. Emami and M. Roach III. M.D. Anderson Cancer Center, Houston, Texas, and University of California at San Francisco. According to the authors' abstract...

Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial. (Periodical Report)
February 8, 1993... SOURCE: Journal of the National Cancer Institute, January 20, 1993;85(2):132-141. Calcium carbonate supplementation at a dosage of 1200 mg elemental calcium daily did not appear to decrease colonic epithelial cell proliferation over an...

Hypothalamic-pituitary dysfunction after radiation for brain tumors. (Periodical Report)
February 8, 1993... SOURCE: The New England Journal of Medicine, January 14, 1993;328(2):87-4. Cranial radiotherapy in children and adults with brain tumors frequently causes abnormal hypothalamic-pituitary function, including hypothryroidism and gonadal...

Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene: relationship to disease-free survival in breast cancer. (Periodical Report)
February 8, 1993... SOURCE: Cancer, January 1, 1993;73(1):162-170. A study reported by a New York research center adds to the evidence that c-myc proto-oncogene amplification and axillary node involvement indicate disease recurrence in breast cancer...

Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. (Periodical Report)
February 8, 1993... SOURCE: Cancer Research, January 15, 1993;53:283-290. DNA amplifications may be acquired during the early initiation and/or promotional events of carcinogenesis, suggesting that altered gene regulation is more important in the...

Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. (Periodical Report)
February 8, 1993... SOURCE: Journal of the National Cancer Institute, January 20, 1993;85(2):147-152. Despite correlation of nm23-H1 allelic deletions with colon cancers associated with poor prognosis, nm23-H1 and nm23-H2 alleles do not directly mediate...

Intensive care prolongs life only a little, at astronomical cost. (H. Lee Moffitt Cancer Center)
February 15, 1993... H. Lee Moffitt Cancer Center Life-prolonging treatment for critically ill cancer patients costs a fortune and usually buys little extra survival, researchers say. They are urging doctors to be sure patients and families really want...

Lesbians found at greater risk of breast cancer. (U.S. National Cancer Institute)
February 15, 1993... U.S. NCI Lesbians have a one-in-three lifetime risk of developing breast cancer, two to three times that of heterosexual women, according to a study by a U.S. National Cancer Institute (NCI) researcher. Suzanne G. Haynes, an...

Scientist develops better way of making taxol. (drug for treating ovarian and breast cancers)(University of Illinois at Urbana-Champaign )
February 15, 1993... University of Illinois at Urbana-Champaign A University of Illinois, Chicago, Illinois, professor has developed what is believed to be the most efficient method of synthesizing Taxol. "It's not a better product but a better method...

Researchers provide information about hereditary ovarian cancer. (Creighton University)
February 15, 1993... Creighton University Researchers at the Creighton University Hereditary Cancer Institute, Omaha, Nebraska, have suggested strategies that should aid in prevention and early diagnosis of hereditary ovarian cancer, according to Dr. Henry...

New procedure to remove rectal tumors reduces hospital stays. (American Society of Colon and Rectal Surgeons)
February 15, 1993... American Society of Colon and Rectal Surgeons A new technique to remove rectal tumors in the upper half of the rectum is less invasive than conventional surgery, reduces pain and risk of complications, and may shorten hospital stays,...

Study suggests major alteration of trial designs of new drugs. (University of Chicago)
February 15, 1993... University of Chicago A new, more rigorous approach can significantly improve the accuracy and speed of standard methods used to determine the recommended doses of new anticancer or anti-AIDS drugs during the first stages of testing,...

Powerful new drugs offer possible treatment for some cancers. (California)
February 15, 1993... California A research team at San Francisco State University's Romberg Tiburon Center, San Francisco, California, has found a new class of drugs that may hold promise for the treatment of AIDS and some cancers. The team, headed by...

Compounds for treatment of hepatitis and human papilloma virus infections developed. (Hoffman-La Roche and Hybridon Inc.)
February 15, 1993... Hoffmann-La Roche and Hybridon Inc. Hybridon Inc., Worcester, Massachusetts, announced it has entered into a research and development collaboration and licensing arrangement with Hoffmann-La Roche Inc., Nutley, New Jersey, together with...

CellPro begins first allogeneic bone-marrow transplantation trial. (CellPro Inc., Bothell, Washington)(Johns Hopkins)
February 15, 1993... Johns Hopkins CellPro Inc., Bothell, Washington, announced that its CEPRATE SC Stem Cell Concentration System is being used to purify stem cells expressing the CD34 antigen (stem cells) from the marrow of donors for use in allogeneic...

AMDL Inc. advances in cancer detection process. (California)
February 15, 1993... California AMDL Inc., Pasadena, California, announced that it has validated the automated testing system required for large-scale clinical trials of RSP (ring-shaped particles) used as a pan-marker for early-phase detection of cancer....

Burlington appointed head of Center for Devices and Radiological Health. (Bruce Burlington, M.D.)(U.S. Food and Drug Administration )
February 15, 1993... U.S. FDA Commissioner of Food and Drugs David A. Kessler, M.D., announced the appointment of Bruce Burlington, M.D., as director of the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health. The...

Executive urges initiative to harmonize sunscreen regulations worldwide. (Richard C. Bartlett)(Mary Kay Corp.)
February 15, 1993... Mary Kay Corporation A senior executive of a U.S. cosmetics company has urged the Health Industry Board of Governors of the World Economic Forum to pursue global uniformity in the regulation of sunscreen products. Richard C....

Group responds to EPA statement on pesticide reform. (Environmental Protection Agency)(National Resources Defense Council)
February 15, 1993... Natural Resources Defense Council The Natural Resources Defense Council (NRDC) said that with the release by the U.S. Environmental Protection Agency (EPA) of a list of 35 carcinogenic pesticides in food that violate the Delaney Clause of...

Absolute safety in foods is unattainable, scientist says. (Dr. Joseph H. Hotchkiss)(Cornell University)
February 15, 1993... Cornell University Fruits and vegetables could cost more and taste worse if Congress refuses to relax a law that bans from food trace amounts of chemicals that cause cancer in animals, according to a Cornell University food scientist and...

Company engineers humanized monoclonal antibody using resurfacing technique. (ImmunoGen Inc.)
February 15, 1993... ImmunoGen Inc. ImmunoGen Inc., Cambridge, Massachusetts, announced that it has successfully developed a humanized antibody using a new technique called resurfacing. The company and its collaborators have filed a patent application...

Breast-implant lawsuits filed. (Michigan)
February 15, 1993... Michigan Thirty-nine additional breast-implant lawsuits were filed on behalf of clients of the Charfoos & Christensen, P.C. law firm, Detroit, Michigan. Defendants include Dow Corning Corporation, McGhan Medical Corporation, Dow...

Study supports antismoking ad strategy. (University of California, San Diego)
February 15, 1993... University of California, San Diego Tobacco advertising targets California youth and encourages them to smoke by associating smoking with many of the social and lifestyle benefits that young people want, according to a new study, "Tobacco...

Procedure may replace surgery for central venous catheter placement. (Society of Cardiovascular and Interventional Radiology)
February 15, 1993... Placement of long-term catheters in the central venous system by interventional radiologists is as effective as surgery and may be safer for patients, according to an article published in the January 1993 issue of the Journal of Vascular and...

Radiation therapy in the treatment of epidemic Kaposi's sarcoma. (Research Report)
February 15, 1993... AUTHORS: Gary R. Graham, Kathryn T. Howell and Jeannie J. Kinzie. Presbyterian Denver Hospital and University of Colorado, Denver, Colorado. According to the authors' abstract of a poster presentation to the 34th annual meeting of the...